The Role of Podoplanin in the Immune System and Inflammation

References

• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435. doi:10.1091/mbc.E10-06-0489
   PubMed Web of Science ®Google Scholar
• Quintanilla M, Montero-Montero L, Renart J, Martin-Villar E. Podoplanin in inflammation and cancer. Int J Mol Sci. 2019;20(3):707. doi:10.3390/ijms20030707
   PubMed Web of Science ®Google Scholar
• Ester M-V, Scholl FG, Carlos G, et al. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer. 2005;113(6). doi:10.1002/ijc.20656
   Web of Science ®Google Scholar
• Ozaki Y, Tamura S, Suzuki-Inoue K. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2. Thromb J. 2016;14(Suppl 1):27. doi:10.1186/s12959-016-0099-8
   PubMedGoogle Scholar
• Suzuki-Inoue K, Tsukiji N, Shirai T, Osada M, Inoue O, Ozaki Y. Platelet CLEC-2: roles beyond hemostasis. Semin Thromb Hemost. 2018;44(2):126–134. doi:10.1055/s-0037-1604090
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Angman L. Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells. Eur J Immunol. 2000;30(2):697–704. doi:10.1002/1521-4141(200002)30:2<697::AID-IMMU697>3.0.CO;2-M
   PubMed Web of Science ®Google Scholar
• Kerrigan AM, Dennehy KM, Mourão-Sá D, et al. CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils. J Immunol. 2009;182(7):4150–4157. doi:10.4049/jimmunol.0802808
   PubMed Web of Science ®Google Scholar
• Acton SE, Astarita JL, Malhotra D, et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity. 2012;37(2):276–289. doi:10.1016/j.immuni.2012.05.022
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Fuller G, García A, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood. 2006;107(2):542–549. doi:10.1182/blood-2005-05-1994
   PubMed Web of Science ®Google Scholar
• Fuller G, Williams J, Tomlinson M, et al. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem. 2007;282(17):12397–12409. doi:10.1074/jbc.M609558200
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ozaki YJ. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost. 2011;9:44–55. doi:10.1111/j.1538-7836.2011.04335.x
   PubMed Web of Science ®Google Scholar
• Martín-Villar E, Megías D, Castel S, Yurrita M, Vilaró S, Quintanilla MJ. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci. 2006;119(21):4541–4553. doi:10.1242/jcs.03218
   PubMed Web of Science ®Google Scholar
• Astarita J, Acton S, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283. doi:10.3389/fimmu.2012.00283
   PubMed Web of Science ®Google Scholar
• Jaime R, Patricia C-R, Beatriz F-M, et al. New insights into the role of podoplanin in epithelial-mesenchymal transition. Int Rev Cell Mol Biol. 2015;317. doi:10.1016/bs.ircmb.2015.01.009
   Web of Science ®Google Scholar
• Harini K, Julie R, Tomoyuki M, et al. Podoplanin: an emerging cancer biomarker and therapeutic target. Cancer Sci. 2018;109(5). doi:10.1111/cas.13580
   Web of Science ®Google Scholar
• Herzog B, Fu J, Wilson S, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature. 2013;502(7469):105–109. doi:10.1038/nature12501
   PubMed Web of Science ®Google Scholar
• Acton S, Astarita J, Malhotra D, et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity. 2012;37(2):276–289. doi:10.1016/j.immuni.2012.05.022
   PubMed Web of Science ®Google Scholar
• Hur J, Jang JH, Oh I-Y, et al. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis. Mol Ther. 2014;22(8):1518–1529. doi:10.1038/mt.2014.61
   PubMed Web of Science ®Google Scholar
• Tal O, Lim H, Gurevich I, et al. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med. 2011;208(10):2141–2153. doi:10.1084/jem.20102392
   PubMed Web of Science ®Google Scholar
• Fuertbauer E, Zaujec J, Uhrin P, et al. Thymic medullar conduits-associated podoplanin promotes natural regulatory T cells. Immunol Lett. 2013;154(1–2):31–41. doi:10.1016/j.imlet.2013.07.007
   PubMed Web of Science ®Google Scholar
• Chen WS, Cao Z, Sugaya S, et al. Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3. Nat Commun. 2016;7(1):11302. doi:10.1038/ncomms11302
   PubMed Web of Science ®Google Scholar
• Youya N, Shigeo S, Mikihiko N, et al. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood. 2008;112(5). doi:10.1182/blood-2007-11-124693
   Web of Science ®Google Scholar
• Ester M-V, Beatriz F-M, Maddy P, et al. Podoplanin associates with CD44 to promote directional cell migration. Mol Biol Cell. 2010;21:24. doi:10.1091/mbc.E10-06-0489
   Web of Science ®Google Scholar
• Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529(7586):307–315. doi:10.1038/nature17039
   PubMed Web of Science ®Google Scholar
• Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6(12):1191–1197. doi:10.1038/ni1276
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S33–S40. doi:10.1016/j.jaci.2009.09.017
   PubMed Web of Science ®Google Scholar
• Gray KJ, Gibbs JE. Adaptive immunity, chronic inflammation and the clock. Semin Immunopathol. 2022;44(2):209–224. doi:10.1007/s00281-022-00919-7
   PubMed Web of Science ®Google Scholar
• Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438(7070):946–953. doi:10.1038/nature04480
   PubMed Web of Science ®Google Scholar
• Peters A, Pitcher L, Sullivan J, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011;35(6):986–996. doi:10.1016/j.immuni.2011.10.015
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Uga H, Tanaka S, et al. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. Mol Immunol. 2013;54(2):199–207. doi:10.1016/j.molimm.2012.11.013
   PubMed Web of Science ®Google Scholar
• Kerrigan AM, Navarro‐nuñez L, Pyz E. Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2. J Thromb Haemost. 2012;10(3):484–486. doi:10.1111/j.1538-7836.2011.04614.x
   PubMed Web of Science ®Google Scholar
• Wynn T, Chawla A, Pollard JJN. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445–455. doi:10.1038/nature12034
   PubMed Web of Science ®Google Scholar
• Hou T, Bystrom J, Sherlock J, et al. A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis. FEBS Lett. 2010;584(18):3955–3961. doi:10.1016/j.febslet.2010.07.053
   PubMed Web of Science ®Google Scholar
• Lawrence T, Natoli GJ. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11(11):750–761. doi:10.1038/nri3088
   PubMed Web of Science ®Google Scholar
• Fei M, Wang H, Zhou M, Deng C, Zhang L, Han Y. Podoplanin influences the inflammatory phenotypes and mobility of microglia in traumatic brain injury. Biochem Biophys Res Commun. 2020;523(2):361–367. doi:10.1016/j.bbrc.2019.12.003
   PubMed Web of Science ®Google Scholar
• Rayes J, Lax S, Wichaiyo S, et al. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Nat Commun. 2017;8(1):2239. doi:10.1038/s41467-017-02402-6
   PubMed Web of Science ®Google Scholar
• Bourne J, Beristain-Covarrubias N, Zuidscherwoude M, et al. CLEC-2 prevents accumulation and retention of inflammatory macrophages during murine peritonitis. Front Immunol. 2021;12:693974. doi:10.3389/fimmu.2021.693974
   PubMed Web of Science ®Google Scholar
• Krishnan H, Ochoa-Alvarez JA, Shen Y, et al. Serines in the intracellular tail of Podoplanin (PDPN) regulate cell motility. J Biol Chem. 2013;288(17). doi:10.1074/jbc.C112.446823
   Web of Science ®Google Scholar
• Cheok Y, Tan G, Fernandez K, et al. Podoplanin drives motility of active macrophage via regulating Filamin C during Helicobacter pylori infection. Front Immunol. 2021;12:702156. doi:10.3389/fimmu.2021.702156
   PubMed Web of Science ®Google Scholar
• Stossel T, Condeelis J, Cooley L, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2(2):138–145. doi:10.1038/35052082
   PubMed Web of Science ®Google Scholar
• Peters A, Pitcher LA, Sullivan JM, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011;35(6):986–996. doi:10.1016/j.immuni.2011.10.015
   PubMed Web of Science ®Google Scholar
• Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41(3):283–297. doi:10.1007/s00281-019-00733-8
   PubMed Web of Science ®Google Scholar
• Nylander AN, Ponath GD, Axisa PP, et al. Podoplanin is a negative regulator of Th17 inflammation. JCI Insight. 2017;2(17). doi:10.1172/jci.insight.92321
   PubMed Web of Science ®Google Scholar
• Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13(10):991–999. doi:10.1038/ni.2416
   PubMed Web of Science ®Google Scholar
• Joller N, Peters A, Anderson A, Kuchroo VJ. Immune checkpoints in central nervous system autoimmunity. Immunol Rev. 2012;248(1):122–139. doi:10.1111/j.1600-065X.2012.01136.x
   PubMed Web of Science ®Google Scholar
• Peters A, Burkett P, Sobel R, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125(1):129–140. doi:10.1172/JCI74685
   PubMed Web of Science ®Google Scholar
• Chihara N, Madi A, Kondo T, et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature. 2018;558(7710):454–459. doi:10.1038/s41586-018-0206-z
   PubMed Web of Science ®Google Scholar
• Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med. 2003;198(12):1807–1815. doi:10.1084/jem.20030725
   PubMed Web of Science ®Google Scholar
• Malhotra D, Fletcher AL, Turley SJ. Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity. Immunol Rev. 2013;251(1):160–176. doi:10.1111/imr.12023
   PubMed Web of Science ®Google Scholar
• Malhotra D, Fletcher A, Astarita J, et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol. 2012;13(5):499–510. doi:10.1038/ni.2262
   PubMed Web of Science ®Google Scholar
• Osada M, Inoue O, Ding G, et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J Biol Chem. 2012;287(26):22241–22252. doi:10.1074/jbc.M111.329987
   PubMed Web of Science ®Google Scholar
• Navarro A, Perez RE, Rezaiekhaligh M, Mabry SM, Ekekezie II. T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2008;295(4):L543–L551. doi:10.1152/ajplung.90262.2008
   PubMed Web of Science ®Google Scholar
• Navarro A, Perez RE, Rezaiekhaligh MH, Mabry SM, Ekekezie II. Polarized migration of lymphatic endothelial cells is critically dependent on podoplanin regulation of Cdc42. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L32–42. doi:10.1152/ajplung.00171.2010
   PubMed Web of Science ®Google Scholar
• Kasinath V, Yilmam O, Uehara M, et al. Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis. Kidney Int. 2019;95(2):310–320. doi:10.1016/j.kint.2018.08.040
   PubMed Web of Science ®Google Scholar
• Astarita J, Cremasco V, Fu J, et al. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat Immunol. 2015;16(1):75–84. doi:10.1038/ni.3035
   PubMed Web of Science ®Google Scholar
• Acton S, Farrugia A, Astarita J, et al. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature. 2014;514(7523):498–502. doi:10.1038/nature13814
   PubMed Web of Science ®Google Scholar
• Kushal K, Moises F-A, Bechberger JF, et al. Podoplanin: a marker for reactive gliosis in gliomas and brain injury. J Neuropathol Exp Neurol. 2015;74(1). doi:10.1097/NEN.0000000000000150
   Web of Science ®Google Scholar
• Song Y, Shen J, Lin Y, et al. Up-regulation of podoplanin involves in neuronal apoptosis in LPS-induced neuroinflammation. Cell Mol Neurobiol. 2014;34(6):839–849. doi:10.1007/s10571-014-0060-y
   PubMed Web of Science ®Google Scholar
• Lax S, Rayes J, Wichaiyo S, et al. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. Am J Physiol Lung Cell Mol Physiol. 2017;313(6):L1016–L1029. doi:10.1152/ajplung.00023.2017
   PubMed Web of Science ®Google Scholar
• Dean RA, Cox JH, Bellac CL, et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, −7, −8, and −13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood. 2008;112(8). doi:10.1182/blood-2007-12-129080
   Web of Science ®Google Scholar
• Eltzschig HK, Eckle T. Ischemia and reperfusion–from mechanism to translation. Nat Med. 2011;17(11):1391–1401. doi:10.1038/nm.2507
   PubMed Web of Science ®Google Scholar
• Meng D, Ma X, Li H, et al. A role of the podoplanin-CLEC-2 axis in promoting inflammatory response after ischemic stroke in mice. Neurotox Res. 2021;39(2):477–488. doi:10.1007/s12640-020-00295-w
   PubMed Web of Science ®Google Scholar
• Kasinath V, Yilmam O, Uehara M, et al. Urine podoplanin heralds the onset of ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol. 2019;316(5):F957–F965. doi:10.1152/ajprenal.00538.2018
   PubMed Web of Science ®Google Scholar
• Hitchcock J, Cook C, Bobat S, et al. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest. 2015;125(12):4429–4446. doi:10.1172/JCI79070
   PubMed Web of Science ®Google Scholar
• Xie Z, Shao B, Hoover C, et al. Monocyte upregulation of podoplanin during early sepsis induces complement inhibitor release to protect liver function. JCI Insight. 2020;5(13). doi:10.1172/jci.insight.134749
   Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361(9):888–898. doi:10.1056/NEJMra0707449
   PubMed Web of Science ®Google Scholar
• Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11(10):763–776. doi:10.1038/nrd3794
   PubMed Web of Science ®Google Scholar
• Noack M, Ndongo-Thiam N, Miossec P. Interaction among activated lymphocytes and mesenchymal cells through podoplanin is critical for a high IL-17 secretion. Arthritis Res Ther. 2016;18(1):148. doi:10.1186/s13075-016-1046-6
   PubMed Web of Science ®Google Scholar
• Weyand C, Kurtin P, Goronzy J. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol. 2001;159(3):787–793. doi:10.1016/S0002-9440(10)61751-8
   PubMed Web of Science ®Google Scholar
• Jones GW, Bombardieri M, Greenhill CJ, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med. 2015;212(11):1793–1802. doi:10.1084/jem.20132307
   PubMed Web of Science ®Google Scholar
• Takakubo Y, Oki H, Naganuma Y, et al. Distribution of podoplanin in synovial tissues in rheumatoid arthritis patients using biologic or conventional disease-modifying anti-rheumatic drugs. Curr Rheumatol Rev. 2017;13(1):72–78. doi:10.2174/1573397112666160331143607
   PubMed Web of Science ®Google Scholar
• Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255. doi:10.1111/j.0105-2896.2009.00859.x
   PubMed Web of Science ®Google Scholar
• Tolboom TCA, van der Helm-Van Mil AHM, Nelissen RG, Breedveld FC, Toes REM, Huizinga TWJ. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 2005;52(7):1999–2002. doi:10.1002/art.21118
   PubMed Web of Science ®Google Scholar
• Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology. 2006;45(6):669–675. doi:10.1093/rheumatology/kel065
   PubMed Web of Science ®Google Scholar
• Baier A, Meineckel I, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol. 2003;15(3):274–279. doi:10.1097/00002281-200305000-00015
   PubMed Web of Science ®Google Scholar
• Karouzakis E, Gay RE, Gay S, Neidhart M. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol. 2009;5(5):266–272. doi:10.1038/nrrheum.2009.55
   PubMed Web of Science ®Google Scholar
• Martín-Villar E, Scholl FG, Gamallo C, et al. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int J Cancer. 2005;113(6):899–910. doi:10.1002/ijc.20656
   PubMed Web of Science ®Google Scholar
• Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006;9(4):261–272. doi:10.1016/j.ccr.2006.03.010
   PubMed Web of Science ®Google Scholar
• Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer. 2007;96(1):1–5. doi:10.1038/sj.bjc.6603518
   PubMed Web of Science ®Google Scholar
• Ekwall A, Eisler T, Anderberg C, et al. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Res Ther. 2011;13(2):R40. doi:10.1186/ar3274
   PubMed Web of Science ®Google Scholar
• Ekwall A-KH, Eisler T, Anderberg C, et al. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Res Ther. 2011;13(2):R40. doi:10.1186/ar3274
   PubMed Web of Science ®Google Scholar
• Mizoguchi F, Slowikowski K, Wei K, et al. Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018;9(1):789. doi:10.1038/s41467-018-02892-y
   PubMed Web of Science ®Google Scholar
• Croft A, Naylor A, Marshall J, et al. Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther. 2016;18(1):270. doi:10.1186/s13075-016-1156-1
   PubMed Web of Science ®Google Scholar
• Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140(4):460–476. doi:10.1016/j.cell.2010.01.045
   PubMed Web of Science ®Google Scholar
• D’Alessio S, Correale C, Tacconi C, et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest. 2014;124(9):3863–3878. doi:10.1172/JCI72189
   PubMed Web of Science ®Google Scholar
• Schacht V, Ramirez MI, Hong Y-K, et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22(14):3546–3556. doi:10.1093/emboj/cdg342
   PubMed Web of Science ®Google Scholar
• Fu J, Gerhardt H, McDaniel JM, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest. 2008;118(11):3725–3737. doi:10.1172/JCI36077
   PubMed Web of Science ®Google Scholar
• Wick N, Haluza D, Gurnhofer E, et al. Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol. 2008;173(4):1202–1209. doi:10.2353/ajpath.2008.080101
   PubMed Web of Science ®Google Scholar
• Kang J, Yoo J, Lee S, et al. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells. Blood. 2010;116(1):140–150. doi:10.1182/blood-2009-11-252270
   PubMed Web of Science ®Google Scholar
• Cueni LN, Detmar M. Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp Cell Res. 2009;315(10):10. doi:10.1016/j.yexcr.2009.02.021
   PubMed Web of Science ®Google Scholar
• Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii SJB. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood. 2003;101(1):168–172. doi:10.1182/blood-2002-03-0755
   PubMed Web of Science ®Google Scholar
• Lee J, Park C, Cho Y, et al. Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Circulation. 2010;122(14):1413–1425. doi:10.1161/CIRCULATIONAHA.110.941468
   PubMed Web of Science ®Google Scholar
• Changming W, Xin L, Hua T, et al. Monocytes can be induced to express lymphatic phenotypes. Lymphology. 2011;44(2).
   PubMed Web of Science ®Google Scholar
• Maruyama K, Nakazawa T, Cursiefen C, et al. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages. Invest Ophthalmol Vis Sci. 2012;53(6):3145–3153. doi:10.1167/iovs.11-8010
   PubMed Web of Science ®Google Scholar
• Kazuichi M, Masaaki I, Claus C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115(9). doi:10.1172/JCI23874
   Web of Science ®Google Scholar
• Maruyama K, Asai J, Ii M, Thorne T, Losordo D, D’Amore P. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170(4):1178–1191. doi:10.2353/ajpath.2007.060018
   PubMed Web of Science ®Google Scholar
• Cimini M, Garikipati VNS, de Lucia C, et al. Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction. JCI Insight. 2019;5. doi:10.1172/jci.insight.126967
   PubMed Web of Science ®Google Scholar
• Cimini M, Kishore R. Role of podoplanin-positive cells in cardiac fibrosis and angiogenesis after ischemia. Front Physiol. 2021;12:667278. doi:10.3389/fphys.2021.667278
   PubMed Web of Science ®Google Scholar
• Abe S, Morita Y, Kaneko MK, et al. A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody. J Immunol. 2013;190(12):6239–6249. doi:10.4049/jimmunol.1300448
   PubMed Web of Science ®Google Scholar
• Chandramohan V, Bao X, Kato Kaneko M, et al. Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int J Cancer. 2013;132(10):2339–2348. doi:10.1002/ijc.27919
   PubMed Web of Science ®Google Scholar
• Shiina S, Ohno M, Ohka F, et al. CAR T cells targeting podoplanin reduce orthotopic glioblastomas in mouse brains. Cancer Immunol Res. 2016;4(3):259–268. doi:10.1158/2326-6066.CIR-15-0060
   PubMed Web of Science ®Google Scholar
• Kaneko MK, Nakamura T, Kunita A, et al. ChLpMab-23: cancer-specific human-mouse chimeric anti-podoplanin antibody exhibits antitumor activity via antibody-dependent cellular cytotoxicity. Monoclon Antib Immunodiagn Immunother. 2017;36(3):104–112. doi:10.1089/mab.2017.0014
   PubMedGoogle Scholar
• Hasan SS, Ashraf GM, Banu N. Galectins - potential targets for cancer therapy. Cancer Lett. 2007;253(1):25–33. doi:10.1016/j.canlet.2006.11.030
   PubMed Web of Science ®Google Scholar
• Pusztai A, Bardocz S, Ewen SWB. Uses of plant lectins in bioscience and biomedicine. Front Biosci. 2008;13(13):1130–1140. doi:10.2741/2750
   PubMed Web of Science ®Google Scholar
• Scholl F, Gamallo C, Vilaró S, Quintanilla MJ. Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes. J Cell Sci. 1999;112(24):4601–4613. doi:10.1242/jcs.112.24.4601
   PubMed Web of Science ®Google Scholar
• Geisler C, Jarvis DL. Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities. Glycobiology. 2011;21(8):988–993. doi:10.1093/glycob/cwr080
   PubMed Web of Science ®Google Scholar
• Wang WC, Cummings RD. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate galactose residues. J Biol Chem. 1988;263(10):4576–4585. doi:10.1016/S0021-9258(18)68821-0
   PubMed Web of Science ®Google Scholar
• Imberty A, Gautier C, Lescar J, Pérez S, Wyns L, Loris R. An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J Biol Chem. 2000;275(23):17541–17548. doi:10.1074/jbc.M000560200
   PubMed Web of Science ®Google Scholar
• Carpintero-Fernandez P, Varela-Eirin M, Lacetera A, et al. New therapeutic strategies for osteoarthritis by targeting sialic acid receptors. Biomolecules. 2020;10(4):637. doi:10.3390/biom10040637
   PubMed Web of Science ®Google Scholar